Kalos Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,369
Closed -$15.7K 321
2023
Q1
$15.7K Buy
+1,369
New +$16.9K 0.03% 172
2022
Q1
Sell
-116,744
Closed -$1.71M 282
2021
Q4
$1.71M Buy
116,744
+9,639
+9% +$136K 0.46% 52
2021
Q3
$1.57M Sell
107,105
-16,213
-13% -$274K 0.44% 55
2021
Q2
$2.11M Buy
123,318
+118
+0.1% +$2.1K 0.86% 26
2021
Q1
$2.17M Buy
123,200
+8,330
+7% +$146K 0.68% 31
2020
Q4
$2.07M Buy
+114,870
New +$1.83M 0.88% 36

Other funds holding SBRA

Kalos Management's SBRA Position: Q2 2023 in Review

Kalos Management sold out of Sabra Healthcare REIT (SBRA) in Q2 2023, closing a stake of 1,369 shares — an estimated $15.7K sold.

Kalos Management first reported a position in SBRA in Q4 2020 and held it in 6 quarters. The position peaked at $2.17M in Q1 2021. 325 funds tracked by Wall St. Rank hold SBRA as of Q2 2023.

  • Kalos Management reported no remaining Sabra Healthcare REIT position as of Q2 2023 after selling out during the quarter.
  • Kalos Management sold 1,369 Sabra Healthcare REIT shares in Q2 2023, an estimated $15.7K.
  • Kalos Management first reported a position in Sabra Healthcare REIT in Q4 2020 and held it in 6 quarters.
  • Kalos Management's Sabra Healthcare REIT position peaked at $2.17M in Q1 2021.
  • 325 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2023.

Based on Kalos Management's 13F filing for Q2 2023, filed 9 Aug 2023.